Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Patrícia de Souza da Silva"'
Autor:
Josilene Ramos Pinheiro-Michelsen, Rayane da Silva Oliveira Souza, Itana Vivian Rocha Santana, Patrícia de Souza da Silva, Erick Carvalho Mendez, Wilson Barros Luiz, Jaime Henrique Amorim
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Dengue Virus (DENV) is an arbovirus (arthropod-borne virus). Four serotypes of DENV are responsible for the infectious disease called dengue that annually affects nearly 400 million people worldwide. Although there is only one vaccine formulation lic
Externí odkaz:
https://doaj.org/article/7e107370e5014f17a5f74b4aa16ed37c
Autor:
Jessica Pires Farias, Patrícia de Souza da Silva, Mayanna Moreira Costa Fogaça, Itana Vivian Rocha Santana, Wilson Barros Luiz, Alexander Birbrair, Jaime Henrique Amorim
Publikováno v:
Journal of virology. 96(8)
COVID-19 continues to spread around the world despite significant progress in vaccine distribution and population immunity. The dynamics of the antiviral antibody response postvaccination is critical to evaluate vaccine effectiveness across different
Autor:
Leandro Dobrachinski, Rodolfo Emanuel Rodrigues da Silva, Isa Bruna Macedo Vitor, Daniela Carvalho de Souza, Patrícia de Souza da Silva, Sílvio Terra Stefanello, Jheiny Stffhany Pimentel Carvalho Glier
Publikováno v:
Ações de Saúde e Geração de Conhecimento nas Ciências Médicas 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::846baf0fbd3f01d2c4d76187576ba33e
https://doi.org/10.22533/at.ed.47820130324
https://doi.org/10.22533/at.ed.47820130324
Autor:
Patrícia de Souza da Silva, Erick Carvalho Mendez, Rayane da Silva Oliveira Souza, Wilson Barros Luiz, Josilene Ramos Pinheiro-Michelsen, Itana Vivian Rocha Santana, Jaime Henrique Amorim
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology, Vol 11 (2020)
Dengue Virus (DENV) is an arbovirus (arthropod-borne virus). Four serotypes of DENV are responsible for the infectious disease called dengue that annually affects nearly 400 million people worldwide. Although there is only one vaccine formulation lic